NEW YORK (GenomeWeb News) – Beckman Coulter has inked a definitive agreement to acquire the Cogenics division of Clinical Data for approximately $17 million, Clinical Data said after the close of the market on Wednesday.

Cogenics provides genomics services, such as DNA sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction, and biobanking. Its services will complement those of Beckman's Agencourt Biosciences business, which also offers genomics services and nucleic acid purification products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.